Endocrinology Flashcards
[diagnosis]
50/F overweight, polyuria, nocturia, weakness, acanthosis nigricans
FBS 140 HBA1C 6
Dx: TDM
Next step: repeat FBS
Initial tx: MNT
Initial medical tx: metformin
recommended age to start screening for DM
Age 45 years old
every 3 years
screen earlier if patient BMI >25 + one additional risk factors for DM
What is the most common pattern of dyslipidemia in DM
Hypertriglyceridemia
Reduced HDL
[Diagnosis of DM]
HbA1c
> = 6.5%
[Diagnosis of DM]
FBS
> =126
[Diagnosis of DM]
2hour plasma 75g OGTT
> = 200
[Diagnosis of DM]
RBS
> = 200 with 3 Ps
What are the contraindications of metformin monotherapy?
- Renal insufficiency
- Any form of acidosis
- Unstable CHF
- Liver disease
- Severe hypoxemia
[DM Treatment]
First line monotherapy drug
Metformin
[DM Treatment]
When will you start dual combination therapy in DM?
A1C >= 9%
[DM Treatment]
When will you start combination injectable therapy in DM?
A1C >= 10%
Metformin is considered for the prevention of T2DM in ____
Prediabetics
- BMI >35
- Age <60
- Prior GDM
- Rising HbA1c
Promotes weight gain
Sulfonylureas
TZD
Insulin
Promotes weight loss
Metformin
SGLT2 inhibitor
GLP1 receptor agonist
Weight neutral
DPP4 inhibitor
What are the effects of incretins affect __ insulin and ___ glucagon
Increase insulin
Decrease glucagon
What are the effects of GLP affect __ glucose, ___ FFA, glucagon
GLP increases glucose
GLP increases FFA
GLP decreases glucagon
What are examples of sulfonylureas?
Gliclazide
Glibenclamide
Glimepiride
Glipizide
Secretagogues
What are examples of non-sulfonylureas?
Repaglinide
Nateglinide
Secretagogues
What are examples of biguanides?
Metformin
insulin sensitizers
What are examples of TZD?
Pioglitazone
insulin sensitizers
What are examples of alpha-glucosidse inhibitors?
Acarbose
Miglitol
inhibit intestinal absorption of sugar
What are examples of DPP-IV inhibitors?
Sitagliptin
Saxagliptin
Linagliptin
Vildagliptin
Incretin-related drugs; prolongs endogenous action of GLP-1
What are examples of GLP-1 agonist?
Exenatide
Liraglutide
Incretin-related drugs; prolongs endogenous action of GLP-1